{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:39:22Z","timestamp":1775237962162,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ejmech.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T08:40:59Z","timestamp":1371026459000},"page":"372-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity"],"prefix":"10.1016","volume":"66","author":[{"given":"Sharad Kumar","family":"Suthar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Lohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikarm","family":"Modak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.06.003_bib1","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/j.bmc.2010.05.072","article-title":"Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity","volume":"18","author":"Marques","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib2","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands: an emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2013.06.003_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0014-827X(00)00079-3","article-title":"Studies on aminopyrazoles: antibacterial activity of some novel pyrazolo[1,5-a]pyrimidines containing sulfonamido moieties","volume":"55","author":"El-Gaby","year":"2000","journal-title":"II Farmaco"},{"key":"10.1016\/j.ejmech.2013.06.003_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0014-827X(01)01178-8","article-title":"Novel synthesis and antifungal activity of pyrrole and pyrrolo[2,3-d]pyrimidine derivatives containing sulfonamide moieties","volume":"57","author":"El-Gaby","year":"2002","journal-title":"II Farmaco"},{"key":"10.1016\/j.ejmech.2013.06.003_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pa.16.040176.001521","article-title":"Relations between structure and biological activity of sulfonamides","volume":"16","author":"Maran","year":"1976","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2013.06.003_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0223-5234(98)80033-0","article-title":"Carbonic anhydrase inhibitors \u2013 part 49: synthesis of substituted ureido and thioureido derivatives of aromatic\/heterocyclic sulfonamides with increased affinities for isozyme I","volume":"33","author":"Supuran","year":"1998","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/0042-6822(92)90464-Z","article-title":"A\u00a0novel quasi-viral agent, MaTu, is a two-component system","volume":"187","author":"Pastorekov\u00e1","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2013.06.003_bib9","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1021\/jm701526d","article-title":"Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs","volume":"51","author":"Thiry","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib10","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","article-title":"Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors","volume":"54","author":"Morris","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1242\/jcs.035022","article-title":"HIF at a glance","volume":"122","author":"Brahimi-Horn","year":"2009","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ejmech.2013.06.003_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10555-007-9064-0","article-title":"Regulation of tumor pH and the role of carbonic anhydrase 9","volume":"26","author":"Swietach","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2013.06.003_bib13","first-page":"255","article-title":"Cancer-related Carbonic Anhydrase Isozymes and Their Inhibition","author":"Pastorekov\u00e1","year":"2004"},{"key":"10.1016\/j.ejmech.2013.06.003_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2013.06.003_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2013.06.003_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2006.09.002","article-title":"Targeting tumorassociated carbonic anhydrase IX in cancer therapy","volume":"27","author":"Thiry","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2013.06.003_bib17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/156802607780636708","article-title":"Carbonic anhydrase inhibitors and the management of cancer","volume":"7","author":"Pastorekov\u00e1","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib18","first-page":"189","article-title":"Synthesis of anti-HIV, anticancer and antitubercular 4-oxo-thiazolidines, 2-imino-4-oxo-thiazolidines and their 5-arylidine derivatives","volume":"33B","author":"Bhatt","year":"1994","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0223-5234(01)01326-5","article-title":"Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds","volume":"37","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib20","first-page":"1399","article-title":"New 6-phenylimidazo[2,1-b]thiazole derivatives: synthesis and antifungal activity","volume":"130","author":"Capan","year":"1999","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib21","first-page":"133","article-title":"Synthesis and anticonvulsant activity of new 4-thiazolidone and 4-thiazoline derivatives","volume":"49","author":"Ergenc","year":"1994","journal-title":"II Farmaco"},{"key":"10.1016\/j.ejmech.2013.06.003_bib22","first-page":"373","article-title":"Some reactions\u00a0of 2-cyanomethylimidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds","volume":"53","author":"Bukowski","year":"1998","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2013.06.003_bib23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0960-894X(01)00304-3","article-title":"Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents","volume":"11","author":"Barreca","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.06.003_bib24","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm049208b","article-title":"Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer","volume":"48","author":"Gududuru","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib25","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1021\/jm7012024","article-title":"Design, synthesis, cytoselective toxicity, structure\u2013activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells","volume":"51","author":"Zhou","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib26","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.bmc.2005.11.017","article-title":"Synthesis of new bioactive venlafaxine analogs: novel thiazolidin-4-ones as antimicrobials","volume":"14","author":"Kavitha","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib27","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.06.003_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2013.06.003_bib29","first-page":"2714","article-title":"Anthocyanins extracted from Chinese blueberry (Vaccinium uliginosum L.) and its anticancer effects on DLD-1 and COLO 205 cells","volume":"123","author":"Zu","year":"2010","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ejmech.2013.06.003_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.canep.2009.06.003","article-title":"Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin","volume":"33","author":"Ho","year":"2009","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ejmech.2013.06.003_bib31","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.7314\/APJCP.2012.13.8.3989","article-title":"Anticancer activity of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica against Dalton's ascetic lymphoma induced solid and ascetic tumor model","volume":"13","author":"Sakthivel","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ejmech.2013.06.003_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-8741(95)01284-K","article-title":"Cytotoxic and anti-tumor properties of certain taxa of umbelliferae with special reference to Centella asiatica (L.) Urban","volume":"48","author":"Babu","year":"1995","journal-title":"J.\u00a0Ethnopharmacol"},{"key":"10.1016\/j.ejmech.2013.06.003_bib33","first-page":"540","article-title":"Cytotoxic and antitumor activity of methonolic extracts desmodium triangulare (retz) merr. root","volume":"4","author":"Jayaseelan","year":"2012","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2013.06.003_bib34","article-title":"Preliminary evaluation of in\u00a0vitro cytotoxicity and in\u00a0vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model","author":"Dhamija","year":"2011","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ejmech.2013.06.003_bib35","series-title":"OECD Guidelines for the Testing of Chemicals: 425 Acute Oral Toxicity \u2013 Up-and-down Procedure (UDP)","first-page":"1","year":"2008"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413003681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413003681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T18:24:41Z","timestamp":1645727081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413003681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":35,"alternative-id":["S0223523413003681"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.06.003","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}